Doxepin 50mg Capsules

Manufacturer AMNEAL Active Ingredient Doxepin Capsules(DOKS e pin) Pronunciation DOKS e pin
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant; Anxiolytic; Hypnotic
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA); Serotonin-Norepinephrine Reuptake Inhibitor (SNRI); Histamine H1 Antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jun 1969
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Doxepin is a medication used to treat depression and anxiety. It works by affecting certain natural chemicals in the brain. It can also cause drowsiness, so it's sometimes used at lower doses to help with sleep. It's important to take it exactly as prescribed and be aware of its side effects.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. If you're taking this medication once a day, take it at bedtime. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.

Storing and Disposing of Your Medication

Store your medication at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a safe location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so. Instead, check with your pharmacist for guidance on the best disposal method. You may also want to explore drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Avoid alcohol and other CNS depressants (e.g., sedatives, sleeping pills) as they can increase drowsiness and other side effects.
  • Do not drive or operate heavy machinery until you know how this medication affects you, as it can cause significant drowsiness and dizziness.
  • Avoid sudden changes in position (e.g., standing up quickly from sitting or lying down) to reduce dizziness and lightheadedness.
  • Maintain good oral hygiene due to potential for dry mouth.
  • Inform your doctor about all other medications, supplements, and herbal products you are taking.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For depression/anxiety: Initial 25-50 mg orally once daily at bedtime or in divided doses. Maintenance 75-150 mg/day. Max 300 mg/day.
Dose Range: 25 - 300 mg

Condition-Specific Dosing:

Depression/Anxiety (mild to moderate): Initial 25-50 mg/day, may increase to 50-150 mg/day. Max 300 mg/day.
Depression/Anxiety (severe): Initial 50 mg/day, may increase to 150-300 mg/day. Max 300 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for depression/anxiety. For pruritus (off-label, >12 years): 10-50 mg/day.
Adolescent: Not established for depression/anxiety. For pruritus (off-label, >12 years): 10-50 mg/day. Black Box Warning for suicidality applies.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required, but monitor for adverse effects.
Moderate: Use with caution; consider lower initial doses and slower titration.
Severe: Use with caution; consider lower initial doses and slower titration. Monitor closely for adverse effects.
Dialysis: Not significantly dialyzable. Use with caution; consider lower doses.

Hepatic Impairment:

Mild: Use with caution; consider lower initial doses and slower titration.
Moderate: Significant dose reduction may be necessary (e.g., 50% or more). Monitor plasma levels if available.
Severe: Contraindicated or significantly reduced dosage (e.g., 75% reduction) with extreme caution. Monitor closely for toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Doxepin is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine (NE) and serotonin (5-HT) at presynaptic neuronal membranes, thereby increasing the concentrations of these neurotransmitters in the synaptic cleft. It also possesses potent antihistaminic (H1), moderate anticholinergic (muscarinic), and moderate alpha-1 adrenergic blocking properties, which contribute to its sedative and adverse effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable (due to extensive first-pass metabolism), approximately 13-45%
Tmax: 2-4 hours (doxepin); 6-12 hours (desmethyldoxepin)
FoodEffect: Food may delay absorption but does not significantly affect the extent of absorption.

Distribution:

Vd: 9-33 L/kg (large volume of distribution)
ProteinBinding: >90%
CnssPenetration: Yes

Elimination:

HalfLife: 10-25 hours (doxepin); 28-52 hours (desmethyldoxepin)
Clearance: Not available (highly variable due to first-pass metabolism)
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: <3% (doxepin); <6% (desmethyldoxepin)
âąī¸

Pharmacodynamics

OnsetOfAction: Sedative effects: within hours; Antidepressant effects: 2-4 weeks
PeakEffect: Antidepressant effects: 4-6 weeks
DurationOfAction: Due to long half-life, effects can persist for 24 hours or more, allowing once-daily dosing.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Doxepin or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Doxepin is not approved for use in pediatric patients.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Fast heartbeat
Difficulty urinating
Feeling extremely nervous or excitable
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Yellowing of the skin or eyes (jaundice)
Ringing in the ears (tinnitus)
Changes in sex drive
Enlarged breasts or nipple discharge
Swelling of the testicles

Important Warning for Asthma Patients

If you have asthma, use this medication with caution. Some people using this medication have experienced worsening of their asthma symptoms. If your asthma symptoms worsen while taking this medication, contact your doctor right away.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild side effects. However, if you notice any of the following side effects or if they bother you or do not go away, contact your doctor or seek medical attention:

Feeling dizzy, sleepy, tired, or weak
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Dry mouth
Changes in taste
Mouth irritation or mouth sores
Weight gain
Excessive sweating
Flushing
Hair loss
* Headache

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or anxiety
  • New or worsening thoughts about suicide or self-harm
  • Unusual changes in behavior (e.g., agitation, restlessness, panic attacks, irritability, aggression, impulsivity, severe insomnia, hypomania, mania)
  • Severe dizziness or fainting spells
  • Fast, pounding, or irregular heartbeat
  • Difficulty urinating or severe constipation
  • Blurred vision or eye pain
  • Confusion or hallucinations
  • Seizures
  • Unexplained fever, sore throat, or unusual bleeding/bruising
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the symptoms you experienced.
Certain health conditions, such as:
+ Difficulty urinating
+ Glaucoma
Current or recent use of specific medications, including:
+ Linezolid or methylene blue
+ Certain antidepressants or Parkinson's disease medications taken within the last 14 days, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline (as this may lead to very high blood pressure)
Use of other medications that can cause drowsiness, as there are many drugs with this potential effect. If you are unsure, consult your doctor or pharmacist.
* If you are breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Before engaging in activities that require your full attention, such as driving, wait until you understand how this medication affects you. The full effects of this drug may not be apparent for several weeks.

To minimize the risk of side effects, do not abruptly stop taking this medication without first consulting your doctor. If you need to discontinue use, your doctor will provide guidance on how to gradually stop taking it.

While taking this medication, it is recommended that you avoid consuming alcohol. Additionally, consult with your doctor before using marijuana, cannabis, or any prescription or over-the-counter medications that may cause drowsiness or impair your reactions.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness around the eye, contact your doctor immediately.

This medication may increase your susceptibility to sunburn. Exercise caution when spending time in the sun, and inform your doctor if you experience excessive sunburn.

If you have diabetes, it is crucial to closely monitor your blood sugar levels. Be aware of the signs of high or low blood sugar, which may include fruity-smelling breath, dizziness, rapid breathing, rapid heartbeat, confusion, sleepiness, weakness, flushing, headache, unusual thirst or hunger, frequent urination, shaking, or sweating. Report any of these symptoms to your doctor.

If you are 65 years or older, use this medication with caution, as you may be more prone to side effects.

Certain medications can affect fertility, potentially impacting your ability to conceive. If you have concerns, discuss them with your doctor.

If you are pregnant or planning to become pregnant, consult with your doctor to weigh the benefits and risks of taking this medication during pregnancy. Using this medication in the third trimester may pose health risks to the newborn, so it is essential to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Confusion or disorientation
  • Severe dry mouth
  • Blurred vision
  • Dilated pupils
  • Fast or irregular heartbeat (tachycardia, arrhythmias)
  • Low blood pressure (hypotension)
  • Urinary retention
  • Seizures
  • Respiratory depression
  • Hypothermia

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment involves supportive care, including maintaining airway, breathing, and circulation, gastric lavage, activated charcoal, and monitoring of cardiac function (ECG).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (e.g., phenelzine, tranylcypromine, selegiline, linezolid, methylene blue): Risk of serotonin syndrome, hyperpyretic crisis, severe convulsions, and death. Allow at least 14 days between discontinuing MAOIs and starting doxepin, and vice versa.
🔴

Major Interactions

  • CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics, antihistamines): Potentiation of CNS depression, including respiratory depression and profound sedation.
  • Anticholinergic Agents (e.g., atropine, scopolamine, benztropine, diphenhydramine): Additive anticholinergic effects (e.g., severe constipation, urinary retention, blurred vision, confusion, paralytic ileus).
  • Sympathomimetics (e.g., epinephrine, norepinephrine, phenylephrine, pseudoephedrine): Potentiation of cardiovascular effects (e.g., hypertension, arrhythmias).
  • CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, quinidine, cimetidine): Increased plasma concentrations of doxepin and desmethyldoxepin, leading to increased risk of adverse effects.
  • Thyroid Hormones (e.g., levothyroxine): Increased risk of cardiac arrhythmias and toxicity.
🟡

Moderate Interactions

  • Antihypertensives (e.g., guanethidine, clonidine, reserpine, beta-blockers): May antagonize the antihypertensive effects of adrenergic neuron blockers; additive hypotensive effects with other antihypertensives.
  • Cimetidine: May inhibit doxepin metabolism, leading to increased plasma levels.
  • Warfarin: May increase or decrease anticoagulant effect; monitor INR.
  • Tramadol: Increased risk of seizures and serotonin syndrome.
đŸŸĸ

Minor Interactions

  • Oral Contraceptives: May alter doxepin metabolism, though clinical significance is usually minor.
  • Tobacco Smoking: May induce CYP1A2, potentially decreasing doxepin levels.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Electrocardiogram (ECG)

Rationale: To assess for pre-existing cardiac conduction abnormalities, especially in elderly patients or those with cardiac disease, due to potential for QTc prolongation and arrhythmias.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: Doxepin is extensively metabolized by the liver; to assess baseline hepatic function.

Timing: Prior to initiation

Renal Function (BUN, Creatinine)

Rationale: To assess baseline renal function, as metabolites are renally excreted.

Timing: Prior to initiation

Mental Status Examination/Suicidal Ideation Assessment

Rationale: To establish baseline psychiatric status and assess risk of suicidality, especially in young adults.

Timing: Prior to initiation

Blood Pressure and Heart Rate

Rationale: To establish baseline cardiovascular parameters due to risk of orthostatic hypotension and tachycardia.

Timing: Prior to initiation

📊

Routine Monitoring

Mental Status Examination/Suicidal Ideation Assessment

Frequency: Weekly for first 4 weeks, then every 2 weeks for next 4 weeks, then monthly for 3 months, and periodically thereafter, or with dose changes.

Target: Improvement in mood/anxiety symptoms; absence of suicidal ideation.

Action Threshold: Worsening depression, emergence of suicidal thoughts, or unusual behavioral changes require immediate re-evaluation and potential dose adjustment or discontinuation.

Blood Pressure (sitting and standing) and Heart Rate

Frequency: Periodically, especially during dose titration and in elderly patients.

Target: Within patient's normal range; minimal orthostatic changes.

Action Threshold: Significant orthostatic hypotension (e.g., >20 mmHg drop in systolic BP) or persistent tachycardia requires intervention (e.g., dose reduction, fluid management).

Adverse Effects Monitoring (e.g., anticholinergic symptoms, sedation)

Frequency: Regularly, especially during initial therapy and dose changes.

Target: Tolerable side effect profile.

Action Threshold: Severe anticholinergic effects (e.g., urinary retention, severe constipation, delirium), excessive sedation, or other intolerable side effects require dose adjustment or alternative therapy.

Weight

Frequency: Periodically

Target: Stable weight or within acceptable range.

Action Threshold: Significant or rapid weight gain may necessitate intervention.

Therapeutic Drug Monitoring (TDM) - Doxepin and Desmethyldoxepin plasma levels

Frequency: Considered for non-responders, suspected non-adherence, or toxicity.

Target: Doxepin + Desmethyldoxepin: 100-250 ng/mL (for depression/anxiety)

Action Threshold: Levels outside therapeutic range may indicate need for dose adjustment or investigation of adherence/metabolism.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, aggression, panic attacks, insomnia, impulsivity, akathisia, hypomania, mania)
  • Blurred vision
  • Dry mouth
  • Urinary retention
  • Constipation
  • Dizziness or lightheadedness (especially upon standing)
  • Sedation or drowsiness
  • Confusion or disorientation (especially in elderly)
  • Irregular heartbeat or palpitations
  • Seizures
  • Muscle stiffness or tremors

Special Patient Groups

🤰

Pregnancy

Category C. Doxepin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited human data suggest potential for neonatal withdrawal symptoms if used late in pregnancy.

Trimester-Specific Risks:

First Trimester: Limited data; potential for increased risk of congenital malformations not definitively established but cannot be ruled out.
Second Trimester: Limited data; generally considered safer than first trimester, but still Category C.
Third Trimester: Potential for neonatal withdrawal symptoms (e.g., respiratory distress, feeding difficulties, irritability, tremors, hypotonia) if exposed near term. Monitor neonate.
🤱

Lactation

Doxepin and its active metabolite are excreted into breast milk. Use with caution. Monitor breastfed infant for sedation, poor feeding, and weight gain.

Infant Risk: L3 (Moderately Safe). Potential for infant sedation, lethargy, poor feeding, and weight loss. Consider alternative agents or monitor infant closely. Higher doses may pose greater risk.
đŸ‘ļ

Pediatric Use

Not approved for depression or anxiety in pediatric patients. Black Box Warning regarding increased risk of suicidal thinking and behavior in children, adolescents, and young adults. Use for other indications (e.g., pruritus) in children >12 years should be done with extreme caution and close monitoring.

👴

Geriatric Use

Elderly patients are more sensitive to the anticholinergic, sedative, and hypotensive effects of doxepin. Increased risk of falls, confusion, urinary retention, and constipation. Start with lower doses (e.g., 10-25 mg/day) and titrate slowly. Avoid if possible in patients with dementia or significant cognitive impairment due to anticholinergic burden.

Clinical Information

💎

Clinical Pearls

  • Doxepin is a potent H1 antagonist, leading to significant sedation. This makes it useful for insomnia (at low doses) but can be a limiting side effect for daytime use.
  • Due to its anticholinergic properties, it should be used with caution or avoided in patients with benign prostatic hyperplasia (BPH), narrow-angle glaucoma, or severe constipation.
  • Orthostatic hypotension is a common side effect, especially in the elderly or those on concomitant antihypertensives. Advise patients to rise slowly.
  • Therapeutic effects for depression may take 2-4 weeks to manifest, while sedative effects are immediate.
  • Plasma level monitoring can be useful in cases of non-response or suspected toxicity, though not routinely performed.
  • The 50mg capsule is typically used for depression/anxiety. Lower doses (e.g., 3-6mg, available as a different formulation, Silenor) are specifically approved for insomnia.
🔄

Alternative Therapies

  • Selective Serotonin Reuptake Inhibitors (SSRIs) (e.g., fluoxetine, sertraline, escitalopram) for depression/anxiety.
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) (e.g., venlafaxine, duloxetine) for depression/anxiety.
  • Other classes of antidepressants (e.g., bupropion, mirtazapine).
  • Benzodiazepines (e.g., lorazepam, alprazolam) for short-term anxiety relief (different mechanism, higher abuse potential).
  • Non-benzodiazepine hypnotics (e.g., zolpidem, eszopiclone) for insomnia.
  • Cognitive Behavioral Therapy (CBT) or other psychotherapies.
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 capsules (50mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure your safety, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information. Please read this guide carefully and review it again whenever you receive a refill. If you have any questions or concerns about this medication, we encourage you to discuss them with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the substance taken, the amount, and the time it occurred.